RemeGen Co Ltd (9995.HK) stock: key figures, P/E, revenue and dividend
Health Care · China · ISIN CNE1000048G6
RemeGen Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.71 bn CNY | 3.24 bn CNY |
| Gross profit | 1.46 bn CNY | 3.45 bn CNY |
| EBIT | -1.50 bn CNY | 765.79 m CNY |
| Net income | -1.47 bn CNY | 709.65 m CNY |
| Diluted EPS – continuing operations | -2.92 CNY | 1.37 CNY |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About RemeGen Co Ltd
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
More stocks
- WARRIOR MET COAL, INC. (HCC)
- Hangzhou Great Star Industrial Co Ltd (002444.SZ)
- Indorama Ventures PCL (IVL.BK)
- OHB (OHB.DE)
- Interpump Group SpA (IP.MI)
- GENTEX CORP (GNTX)
- TIZA Information Industry Corporation Inc (300209.SZ)
- GEK Terna SA (GEKTERNA.AT)
- Sk Biopharmaceuticals Co Ltd (326030.KS)
- UFP INDUSTRIES INC (UFPI)
- Sega Sammy Holdings Inc (6460.T)
- HERC HOLDINGS INC (HRI)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.